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ABSTRACT
Objective: In the last few years the genetic influence
on health and disease outcome has become more
apparent. The ACE genotype appears to play a
significant role in the pathophysiology of several
disease processes. This pilot study aims at showing
the feasibility to examine the genetic influence of the
ACE genotype on return of spontaneous circulation
(ROSC) in out-of-hospital cardiac arrest (OHCA).
Methods: We performed a prospective observational
study of all OHCAs of presumed cardiac origin in a
well-defined population. We collected prehospital blood
samples for the determination of ACE genotype and
used this information together with Utstein template
parameters in a multivariable analysis to examine the
relationship between ROSC and ACE genotype.
Results: We collect blood samples in 156 of 361
patients with OHCA of presumed cardiac origin, 127
samples were analysed (mean age 67 years, 86% male,
79% witnessed OHCA, 80% bystander CPR, 62% had
a shockable rhythm, ROSC 77%). Distribution of the
ACE gene polymorphisms: insertion polymorphism (II)
n=22, 17%, insertion/deletion polymorphism (ID)
n=66, 52% and deletion polymorphism (DD) n=39,
31%. We found no significant association between ACE
II vs ACE DD/DI and ROSC (OR 1.72; CI 0.52 to 5.73;
p=0.38). Other ACE genotype groupings (II/ID vs DD or
II vs DD) did not change the overall finding of lack of
impact of ACE genotype on ROSC.
Conclusions: This pilot study did not indicate a
significant association between ACE gene
polymorphism and ROSC. However, it has
demonstrated that prehospital genetic studies including
blood sampling are feasible and ethically acceptable.
INTRODUCTION
Despite more than 1000 cases of out-of-hospital
sudden cardiac arrest (OHCA) occurring
throughout Europe every day, neurologically
intact survival remains poor; currently no more
than 10–25% in the best emergency medical
systems (EMS).1 2 Even when the entire chain
of survival is working efficiently and effectively,
outcome is difficult to predict, reflecting the
many factors, both known and unknown, that
contribute to overall survival. While many
important predictors for survival are under-
stood, such as an initial shockable rhythm, a
witnessed arrest and bystander cardiopulmon-
ary resuscitation (CPR), many other more
subtle predictors are likely to be in play.3
In many areas of medicine, the genetic
influence on health, disease progression and
response to therapy is becoming apparent.
The understanding of genetic-based altera-
tions and diseases of the human body has
expanded enormously during the past
20 years.4 Several correlations between
genetic polymorphism and increased risk for
disease development and outcome have
KEY MESSAGES
What is already known about this subject?
▸ We know the significant effects of angiotensin
converting enzyme (ACE) genotype on survival
from critical illness and major trauma. The ACE
genotype is contributing to vascular tone and
therefore we decided to perform a pilot study of
the relationship between ACE genotype and
return of spontaneous circulation in patients
with out of hospital cardiac arrest.
What does this study add?
▸ This pilot study has demonstrated the feasibility
of collecting blood samples from out of hospital
cardiac arrest patients even if not admitted to
the receiving hospital later and showed how
practical, legal and ethical challenges might be
overcome in such pre-hospital studies.
How might this impact on clinical practice?
▸ More knowledge on the genetic influence on
return of spontaneous circulation rate may affect
how we treat such out-of-hospital cardiac arrest
patients and lead to improved prognosis.
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since been established and it is likely that a genetic com-
ponent determines response to some of the many patho-
physiological pathways at play during attempted
resuscitation from OHCA.5
An important determinant of return of spontaneous cir-
culation (ROSC) during resuscitation from OHCA is the
diastolic blood pressure generated during external cardiac
chest compressions; this determining the subsequent cor-
onary perfusion pressure.6
Vascular tone is a major factor determining diastolic
blood pressure during CPR and is known to be influ-
enced by genetic polymorphism of the angiotensin con-
verting enzyme (ACE) gene.6–8 The peptide hormone
angiotensin II (AGII) is part of the renin–angiotensin–
aldosterone system which controls blood pressure regula-
tion. AGII acts to constrict vascular smooth muscle
resulting in increased vascular tone and therefore
increased blood pressure. The ACE gene has three geno-
types: insertion polymorphism (II); insertion/deletion
polymorphism (ID) and deletion polymorphism (DD).
The absence (deletion, D) rather than the presence
(insertion, I) of a 287 base pair fragment in the ACE
gene is associated with higher circulating and tissue ACE
activity.7 8 This genetic effect accounts for 47% of the
total variance of serum ACE.7
The ACE genotype appears to play a significant role in
the pathophysiology of several disease processes,
although the exact mechanisms are poorly understood.
In patients with the DD/DI genotype, excess mortality
has been shown in adult acute respiratory distress syn-
drome 9 and paediatric meningococcal infection10 and
the genotype has also been linked to trauma survival
and worse functional outcome from traumatic brain
injury.11 12
In view of the significant effects on ACE genotype on
survival from critical illness and major trauma and the
role of the ACE genotype in determining vascular tone,
we decided to perform a pilot study of the relationship
between ACE genotype and outcome from OHCA of
presumed cardiac cause. We felt such a pilot study focus-
ing on feasibility could generate valuable information
for future genetic OHCA studies independent of its
findings. Hence, we established a study protocol with
ethical approval, which made it possible to collect blood
samples from OHCA victims with ongoing resuscitation
or return of spontaneous circulation, to analyse the ACE
genotype in OHCA victims in Western Norway.
METHODS
Study design
We performed a prospective observational study of all
patients suffering OHCA in the Stavanger region of
Norway; an area with a primarily Caucasian population
of about 320 000.13 During the study period (February
2007—November 2010), the EMS responded to 787
emergency calls to patients with OHCA, of which a
presumed cardiac origin, according to the Utstein defi-
nitions,14 15 was found in 361 patients (figure 1).
System overview
All OHCA patients with ROSC in the study region are
transported to one hospital—the Stavanger University
Hospital. The dispatch and EMS from the study area has
been described previously.2 16 In summary, a single
alarm and dispatch centre is responsible for all call-outs
of ambulance units, including a physician-manned unit,
either by air or road. The alarm and dispatch centre
also advises bystanders in CPR, including mouth-to-
mouth ventilation. System outcome data has recently
been published.2
Clinical care
During the study period, all patients suffering OHCA
and recruited to the study received advanced life
support from the ambulance crew. In addition to the
paramedic crew, a doctor was dispatched to all cases of
OHCA. The 2005 European Resuscitation Council
(ERC) resuscitation guidelines with Norwegian altera-
tions were in use for all patients in this study.17
Termination of CPR mostly occurred on scene and
was decided by an attending medical professional
(general practitioner on call or physician-manned rapid
response unit) according to local protocol.2 A minority
of patients were admitted to hospital with ongoing CPR
and subsequently entered into the appropriate group,
depending on whether ROSC was achieved in the emer-
gency department.
Ethical considerations
All EMS paramedics who participated in the blood
sample collection process received teaching in technical
and ethical aspects of the study. The study and the use
Figure 1 Flow chart of 787 patients with out-of-hospital
cardiac arrest between February 2007 and November 2010
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of local databases were approved by the Norwegian
Social Science Data Service, the Regional Committee for
Research Ethics and the local EMS. The Regional
Committee for Research Ethics accepted that no
informed consent could be obtained before blood sam-
pling from the patient or from the next-of-kin.
Therefore, informed consent was obtained retrospect-
ively, either from the patients directly if they regained
the ability to consent after the treatment for their
OHCA or from the next-of-kin in cases where the
patient did not survive or did not make sufficient neuro-
logical recovery to give informed consent. If informed
consent from next-of-kin was necessary this was obtained
several weeks after the OHCA event to allow next-of-kin
to recover from their severe loss. Oral and written infor-
mation was given by the investigators to those giving
consent and signed approval was obtained.
Cardiac arrest registry
All patients treated for OHCA by the EMS routinely
have their details entered into the hospital-owned
Utstein-based database. For this study the Utstein-
based14 15 database was accessed for all included patients
to extract the OHCA data for further analysis. Origin of
the OHCA was determined prehospital following the
Utstein recommendations.14 15 For quality assurance,
data were crossed-checked before being entered in the
study database. Missing data for each performed analysis
are noted in the Results section
Collection of genetic material
The collection of blood samples was performed by the
EMS paramedics without either disturbing or delaying
the standard CPR protocol. Samples were either drawn
on scene or in patients with ROSC, following transport
to the hospital. Most of the blood samples were there-
fore obtained either after establishing ROSC or once
CPR efforts were terminated. If the resuscitation efforts
were terminated on scene, the deceased was, according
to local law, no longer in the sphere of responsibility of
the EMS. Therefore, no blood samples could be col-
lected after death was declared by the on-scene phys-
ician. In order to improve recruitment, 10 additional
blood samples were collected in the Bergen region,
which have a similar EMS physician-manned service.18 19
Blood was drawn from an intravenous cannula in a
peripheral vein, either from a cannula prior to adminis-
tration of drugs or fluids, or from a separate unused
intravenous cannula. Up to 20 mL venous blood was
withdrawn into two 10 mL glass tubes coated with EDTA.
These samples were transferred to the hospital, either
together with the patient or by the EMS alone and,
without further processing, stored at −80°C. The genetic
analysis was performed as a single batch after all samples
had been obtained.
Genetic analysis
Genomic DNA from 1 mL of whole blood was extracted
using Qiagen Genomic-tip 20/G (QIAGEN AB;
SE-19124 Sollentuna) according to manufacturer’s
instructions.20 The eluted DNA was precipitated and dis-
solved. The ACE polymorphism analysis was determined
using PCR under standard conditions described else-
where.21 One microliter of the PCR reaction product is
analysed by capillary electrophoresis using a
microfluidics-based platform for sizing, quantification
and quality control of DNA (Agilent 2100 Bioanalyzer)
to separate the 191 bp-long D variant from the
478 bp-long I variant.
Statistical analysis
Data were entered into a FilemakerPro7 database
(FileMaker, Inc; USA), and SPSS V.20.0 (SPSS, Inc;
USA) was used for statistical analysis. Figures were con-
structed using MicrosoftOffice 2010 (Microsoft
Corporation, USA). A χ2 test was used to examine differ-
ences in proportions for categorical variables. Student
t test and analysis of variance were used to examine
between-group differences for continuous variables.
A multiple logistic regression model was constructed.
Goodness of fit for the logistic regression model was veri-
fied by the Hosmer-Lemeshow test.
Two-sided p values <0.05 were considered statistically
significant. Missing data occurred in several variables
examined in this study. Information on the missing data
is shown in the tables if the missing data comprised
more than 5% of all data collected for the variable. The
numbers of complete data sets are reported for the mul-
tivariable analyses.
The presentation of the three ACE gene polymorph-
isms were carried out separately, but also aggregated in
two groups; ACE II against ACE DD/ID as described by
Kehoe.12
RESULTS
Of the 361 patients with an OHCA of presumed cardiac
origin, 156 had blood samples drawn (figure 1). A total
of 127 blood samples were eligible for genetic poly-
morphism analysis, while a further 29 blood samples
were not analysed due to lack of informed consent.
Table 1 shows the demographic and clinical character-
istics of the study population and the univariate analysis
of factors linked to ROSC, which was achieved in 59% of
the studied patients.
Table 2 shows the demographic and clinical character-
istics of the study population stratified by the ACE geno-
type groups II against ID+DD, while table 3 presents the
association between ACE genotype and ROSC, adjusted
for demographic and clinical factors. The univariate
analysis indicated a possible association between ROSC
rate and ACE gene polymorphism (table 2; p=0.15).
However, we did not find a significant relationship
between ACE genotype and ROSC in the multivariable
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analysis (table 3). Comparing other ACE genotype
groupings (II/ID vs DD or II vs DD) did not change the
overall finding of lack of impact of ACE genotype on
ROSC.
DISCUSSION
The aim of our pilot study was to show the feasibility to
examine the genetic influence between ACE genotype
and ROSC in OHCA of presumed cardiac origin. We
could not demonstrate such a relationship between ACE
genotype and ROSC in OHCA victims. Had the
association of ACE genotype with ROSC been as strong
as that reported with survival from major trauma,12 we
would have expected to see a significant association
despite the relatively small number of patients studied.
Although probably related to mechanisms other than
vascular tone, ACE gene polymorphism has also shown a
strong association in other diseases where it determines
variations in acute lung injury in sepsis,22 23 impaired
lung function9 and recovery from traumatic brain
injury.11 In western Caucasian population such as ours,
the distribution of the ACE genotype is expected to be
II 25%, ID 50% and DD 25%.24–27 This is similar to the







Age, year, mean (SD) 67 (15) 65 (14) 70 (15) 0.042
Male sex, n (%) 109 (86) 66 (88) 43 (83) 0.399
Witnessed OHCA, n (%) 100 (79) 65 (87) 35 (67) 0.014
Bystander CPR, n (%) 102 (80) 63 (84) 39 (75) 0.210
Location OHCA home, n (%) md=31 63 (50) 31 (41) 32 (62) 0.436
EMS response time in minutes; mean (SD) 9 (6) 8 (5) 11 (6) 0.019
First rhythm shockable, n (%) 79 (62) 58 (77) 21 (40) <0.001
ACE II, n (%) 22 (17) 16 (21) 6 (12) 0.151
ACE ID, n (%) 66 (52) 37 (49) 29 (55) 0.765
ACE DD, n (%) 39 (31) 22 (29) 17 (33) 0.162
DD, deletion polymorphism; II, insertion polymorphism; ID, insertion/deletion polymorphism; ROSC, return of spontaneous circulation.






n=105, (83%) p Value
Age, year, mean (SD) 67 (15) 69 (18) 67(14) 0.527
Male sex, n (%) 109 (86) 21 (95) 88 (84) 0.154
Witnessed OHCA, n (%) 100 (79) 17 (77) 83 (79) 0.853
Bystander CPR, n (%) 102 (80) 19 (86) 83 (79) 0.432
Location OHCA home, n (%) md=31 63 (50) 11 (50) 52 (50) 0.946
EMS response time in minutes; Mean (SD) 9 (6) 7 (5) 10 (6) 0.092
First rhythm shockable, n (%) 79 (62) 15 (68) 64 (61) 0.525
ROSC n (%) 75 (59) 16 (73) 59 (56) 0.151
DD, deletion polymorphism; II, insertion polymorphism; ID, insertion/deletion polymorphism; ROSC, return of spontaneous circulation.
Table 3 Factors associated with ROSC in the study population (n=127)
OR 95% CI p Value
Age (one additional year) 0.98 0.95 to 1.00 0.117
Gender (female) 1.98 0.56 to 6.96 0.287
Witnessed OHCA 3.07 0.98 to 9.65 0.055
Shockable rhythm 5.28 2.03 to 13.72 0.001
EMS response time (one additional minute) 0.90 0.83 to 0.98 0.015
ACE genotype
ACE II/ACE (DD+ID) 1.72 0.52 to 5.73 0.377
Missing data 7.
ACE, angiotensin converting enzyme; DD/ID, deletion polymorphism/insertion/deletion polymorphism; II, insertion polymorphism; OHCA, out-
of-hospital cardiac arrest; ROSC, return of spontaneous circulation.
4 Lindner TW, Deakin CD, Aarsetøy H, et al. Open Heart 2014;1:e000138. doi:10.1136/openhrt-2014-000138
Open Heart
distribution found in our small patient cohort and that
of the population of trauma patients demonstrating a
strong association of ACE genotype with outcome.12
Recent ACE genotype research has failed to demon-
strate an association with outcome in several cardiac dis-
eases28 and has also demonstrated the multifactorial
nature of the control of vascular tone.29–31
ACE gene polymorphism controlling angiotensin path-
ways may only be one of several physiological mechan-
isms to influence the effect of vascular tone on
promoting adequate diastolic blood pressure to achieve
ROSC during OHCA. ACE genotype alone as a marker
of risk in disease processes may well be too simplistic an
approach to understanding the effects of genotype on
disease processes. A more targeted approach and larger
sample sizes may be appropriate for future studies.
Since the inception of this study, more specific methods
of analysing ACE genotype and associated metabolic
pathways have become available, such as measured-
haplotype analysis of single nucleotide polymorphisms23
and future studies may be better directed using these
methods.
Where genotype is associated with a specific pheno-
typic defect, rather than a subtle influence on metabolic
pathways, a clearer association with genotype is often
apparent. A number of studies have demonstrated that
sudden cardiac death has a strong genetic component,
particularly in association with structural defects and
sudden malignant arrhythmias.32 A number of other
genetic polymorphisms have all been associated with an
altered risk of coronary artery disease and myocardial
infarction which are indirect risk factors for cardiac
arrest.33 An understanding of the genetic contributions
to outcome from resuscitation could add substantially to
the prediction and management of cardiac arrest and is
a goal worth pursuing. We therefore believe that the
main value of our pilot study is to serve as a feasibility
model for future prehospital genetic studies in OHCA
victims unable to give informed consent.
With regard to our study design, we believe that the
present study has demonstrated the practical and ethical
feasibility of collecting blood samples from patients in
the prehospital arena, even if not admitted to the receiv-
ing hospital later. This design facilitates the collection of
important information from OHCA victims who were
declared dead on the scene even if no blood was drawn
after declaration of death as described by Johnson.34
The approach used in this study can be used as an
example for other studies where human material needs
to be collected. The ethical details are applicable to
other research studies in the prehospital arena. The
ethical aspects of this study were universally accepted by
EMS personal, but we found that about 20% of patients
and/or relatives later declined to give informed consent.
The main reason to decline informed consent from rela-
tives was the wish not to be reminded about the death of
the deceased and therefore the unwillingness of involve-
ment. Some patients and/or relatives were
uncontactable, thus preventing the use of these samples
and data in the study.
In summary this demonstrates that it is possible to
conduct genetic research in the ethically challenging
prehospital environment with patients unable to give
consent, but that studies must take into account a
relatively large drop-out rate. Our experience also indi-
cates that there may be a need for extra staff on
scene, responsible solely for collection of biological
specimens.
Limitations
The major limitation of this study is the small sample
size, which is of particular relevance for genetic studies
that often require sample size orders of a magnitude
much greater than was possible in our study.33 34 The
small patient cohort studied may also explain why other
factors like age and witnessed OHCA did not show sig-
nificant associations with ROSC.
A main concern in the present pilot study was that the
delivery of advanced life support by EMS crews should
not be interrupted by the need to obtain a blood
sample for the study. It was only possible to collect blood
samples when enough resources were present at the
OHCA scene. Several patients could not be included
due to this limitation. Other ethical or logistical consid-
erations on scene may also have influenced the inclusion
of patients when effort was focussed on the resuscitation
attempt. This may have inflated the proportion of
patients with ROSC in our study cohort and thus limited
the sample size in the comparator group.
CONCLUSIONS
This pilot study of 127 OHCA victims did not demon-
strate a clear association between ACE gene polymorph-
ism and ROSC, and was limited in its interpretation by
the relatively small sample size. However, the pilot study
has demonstrated the feasibility of collecting blood
samples from patients with OHCA and demonstrates
how practical, legal and ethical challenges might be
overcome in such pre-hospital studies. More pre-hospital
genetic studies in adequately powered cohorts of OHCA
victims will help move forward the frontier of genetic
influence on resuscitation outcomes.
Author affiliations
1Department of Anaesthesiology and Intensive Care, Stavanger University
Hospital, Stavanger, Norway
2South Central Ambulance Service NHS Foundation Trust, Otterbourne, UK
3NIHR Southampton Respiratory Biomedical Research Unit, Southampton
University Hospital NHS Foundation Trust, Southampton, UK
4School of Health Sciences, University of Surrey, UK
5Department of Medicine, Stavanger University Hospital, Stavanger, Norway
6Department of Surgical Sciences, Anaesthesiology and Critical Care
Medicine, Uppsala University, Uppsala, Sweden
7Department of Anaesthesia and Intensive Care, Haukeland University
Hospital, Bergen, Norway
8Department of Clinical Medicine, University of Bergen, Bergen, Norway
Lindner TW, Deakin CD, Aarsetøy H, et al. Open Heart 2014;1:e000138. doi:10.1136/openhrt-2014-000138 5
Arrhythmias and sudden death
Acknowledgements The authors are deeply grateful to the EMS employees
who made this work possible. They delivered much more than expected. In
addition, the authors want to thank Astrid Våge and Wenche Mathiesen for
their supportive work in the analysing process and Lars Wiklund and Cecile
Martijn who made the genetic analysis possible.
Competing interests None.
Ethics approval Regional committee for medical and health research ethics
Bergen Norway.
Provenance and peer review Not commissioned; externally peer reviewed.
Open Access This is an Open Access article distributed in accordance with
the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license,
which permits others to distribute, remix, adapt, build upon this work non-
commercially, and license their derivative works on different terms, provided
the original work is properly cited and the use is non-commercial. See: http://
creativecommons.org/licenses/by-nc/4.0/
REFERENCES
1. Berdowski J, Berg RA, Tijssen JG, et al. Global incidences of
out-of-hospital cardiac arrest and survival rates: systematic review of
67 prospective studies. Resuscitation 2010;81:1479–87.
2. Lindner TW, Soreide E, Nilsen OB, et al. Good outcome in every
fourth resuscitation attempt is achievable—an Utstein template
report from the Stavanger region. Resuscitation 2011;82:1508–13.
3. Sasson C, Rogers MA, Dahl J, et al. Predictors of survival from
out-of-hospital cardiac arrest: a systematic review and meta-analysis.
Circ Cardiovasc Qual Outcomes 2010;3:63–81.
4. Lander ES, Linton LM, Birren B, et al. Initial sequencing and
analysis of the human genome. Nature 2001;409:860–921.
5. Royse SD. Implications of genetic testing for sudden cardiac death
syndrome. Br J Nurs 2006;15:1104–7.
6. Paradis NA, Martin GB, Rivers EP, et al. Coronary perfusion
pressure and the return of spontaneous circulation in human
cardiopulmonary resuscitation. JAMA 1990;263:1106–13.
7. Rigat B, Hubert C, Alhenc-Gelas F, et al. An insertion/deletion
polymorphism in the angiotensin I-converting enzyme gene
accounting for half the variance of serum enzyme levels. J Clin
Invest 1990;86:1343–6.
8. Tiret L, Rigat B, Visvikis S, et al. Evidence, from combined
segregation and linkage analysis, that a variant of the angiotensin
I-converting enzyme (ACE) gene controls plasma ACE levels. Am J
Hum Genet 1992;51:197–205.
9. Marshall RP, Webb S, Bellingan GJ, et al. Angiotensin converting
enzyme insertion/deletion polymorphism is associated with
susceptibility and outcome in acute respiratory distress syndrome.
Am J Respir Crit Care Med 2002;166:646–50.
10. Harding D, Baines PB, Brull D, et al. Severity of meningococcal
disease in children and the angiotensin-converting enzyme insertion/
deletion polymorphism. Am J Respir Crit Care Med
2002;165:1103–6.
11. Ariza M, Matarin MD, Junque C, et al. Influence of
angiotensin-converting enzyme polymorphism on
neuropsychological subacute performance in moderate and severe
traumatic brain injury. J Neuropsychiatry Clin Neurosci
2006;18:39–44.
12. Kehoe AD, Eleftheriou KI, Heron M, et al. Angiotensin-converting
enzyme genotype may predict survival following major trauma.
Emerg Med J 2008;25:759–61.
13. Statistics-Norway. Population Figures Statistics Norway. http://www.
ssb.no/english/subjects/02/befolkning_en/ 2009 (accessed 2009).
14. Cummins RO, Chamberlain D, Hazinski MF, et al. Recommended
guidelines for reviewing, reporting, and conducting research on
in-hospital resuscitation: the in-hospital ‘Utstein style’. American
Heart Association. Circulation 1997;95:2213–39.
15. Jacobs I, Nadkarni V, Bahr J, et al. Cardiac arrest and
cardiopulmonary resuscitation outcome reports: update and
simplification of the Utstein templates for resuscitation registries.
A statement for healthcare professionals from a task force of the
international liaison committee on resuscitation (American Heart
Association, European Resuscitation Council, Australian
Resuscitation Council, New Zealand Resuscitation Council, Heart
and Stroke Foundation of Canada, InterAmerican Heart Foundation,
Resuscitation Council of Southern Africa). Resuscitation
2004;63:233–49.
16. Langhelle A, Tyvold SS, Lexow K, et al. In-hospital factors
associated with improved outcome after out-of-hospital cardiac
arrest. A comparison between four regions in Norway. Resuscitation
2003;56:247–63.
17. Lexow K, Sunde K. Why Norwegian 2005 guidelines differs slightly
from the ERC guidelines. Resuscitation 2007;72:490–2.
18. Heradstveit BE, Sunde K, Sunde GA, et al. Factors complicating
interpretation of capnography during advanced life support in cardiac
arrest—a clinical retrospective study in 575 patients. Resuscitation
2012;83:813–18.
19. Lindner T, Langorgen J, Sunde K, et al. Factors predicting the use of
therapeutic hypothermia and survival in unconscious out-of-hospital
cardiac arrest patients admitted to the ICU. Critical care 2013;17:
R147.
20. QIAGEN. QIAGEN Genomic DNA Handbook. Secondary QIAGEN




21. Takemoto Y, Sakatani M, Takami S, et al. Association between
angiotensin II receptor gene polymorphism and serum angiotensin
converting enzyme (SACE) activity in patients with sarcoidosis.
Thorax 1998;53:459–62.
22. Jerng JS, Yu CJ, Wang HC, et al. Polymorphism of the
angiotensin-converting enzyme gene affects the outcome of acute
respiratory distress syndrome. Crit Care Med 2006;34:1001–6.
23. Nakada TA, Russell JA, Boyd JH, et al. Association of angiotensin II
type 1 receptor-associated protein gene polymorphism with
increased mortality in septic shock. Crit Care Med 2011;39:1641–8.
24. Cambien F, Poirier O, Lecerf L, et al. Deletion polymorphism in the
gene for angiotensin-converting enzyme is a potent risk factor for
myocardial infarction. Nature 1992;359:641–4.
25. Danser AJ, Schalekamp MA, Bax WA, et al. Angiotensin-converting
enzyme in the human heart effect of the deletion/insertion
polymorphism. Circulation 1995;92:1387–88.
26. Marian A, Yu Q, Workman R, et al. Angiotensin-converting enzyme
polymorphism in hypertrophic cardiomyopathy and sudden cardiac
death. Lancet 1993;342:1085–86.
27. Schunkert H, Hense H-W, Holmer SR, et al. Association between a
deletion polymorphism of the angiotensin-converting-enzyme gene
and left ventricular hypertrophy. New Engl J Med
1994;330:1634–38.
28. Bernstein KE, Ong FS, Blackwell WL, et al. A modern understanding
of the traditional and nontraditional biological functions of
angiotensin-converting enzyme. Pharmacol Rev 2013;65:1–46.
29. Rieder MJ, Taylor SL, Clark AG, et al. Sequence variation in the
human angiotensin converting enzyme. Nat Genet 1999;22:59–62.
30. Sayed-Tabatabaei FA, Oostra BA, Isaacs A, et al. ACE
polymorphisms. Circ Res 2006;98:1123–33.
31. Wu CK, Tsai CT, Chang YC, et al. Genetic polymorphisms of the
angiotensin II type 1 receptor gene and diastolic heart failure.
J Hypertens 2009;27:502–7.
32. Noseworthy PA, Newton-Cheh C. Genetic determinants of sudden
cardiac death. Circulation 2008;118:1854–63.
33. Yende S, Wunderink RG. Genetic polymorphisms that predict
outcome and need for treatment in cardiovascular disease. Curr
Opin Crit Care 2006;12:420–5.
34. Johnson C, Lemaitre R, Fahrenbruch C, et al. Common variation in
fatty acid genes and resuscitation from sudden cardiac arrest. Circ
Cardiovasc Genet 2012;5:422–9.
6 Lindner TW, Deakin CD, Aarsetøy H, et al. Open Heart 2014;1:e000138. doi:10.1136/openhrt-2014-000138
Open Heart
